South America Biosimilars Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. South America Biosimilars Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. South America Biosimilars Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. South America Biosimilars Market Regional Analysis

6.2 South America Biosimilars Market Revenue 2020-2028 (US$ Million)

6.3 South America Biosimilars Market Forecast Analysis

7. South America Biosimilars Market Analysis – by Disease Indication

7.1 Cancer

7.1.1 Overview
7.1.2 Cancer: South America Biosimilars Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Diabetes

7.2.1 Overview
7.2.2 Diabetes: South America Biosimilars Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 Autoimmune Diseases

7.3.1 Overview
7.3.2 Autoimmune Diseases: South America Biosimilars Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.4 Other Diseases

7.4.1 Overview
7.4.2 Other Diseases: South America Biosimilars Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. South America Biosimilars Market Analysis – by Drug Class

8.1 Granulocyte Colony-Stimulating Factors

8.1.1 Overview
8.1.2 Granulocyte Colony-Stimulating Factors: South America Biosimilars Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Human Growth Hormone

8.2.1 Overview
8.2.2 Human Growth Hormone: South America Biosimilars Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.3 Insulin

8.3.1 Overview
8.3.2 Insulin: South America Biosimilars Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.4 TNF Blockers & Monoclonal Antibodies

8.4.1 Overview
8.4.2 TNF Blockers & Monoclonal Antibodies: South America Biosimilars Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.5 Erythropoietin-Stimulating Agents

8.5.1 Overview
8.5.2 Erythropoietin-Stimulating Agents: South America Biosimilars Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. South America Biosimilars Market Analysis – by Route of Administration

9.1 Intravenous

9.1.1 Overview
9.1.2 Intravenous: South America Biosimilars Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Subcutaneous

9.2.1 Overview
9.2.2 Subcutaneous: South America Biosimilars Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. South America Biosimilars Market Analysis – by End User

10.1 Hospitals

10.1.1 Overview
10.1.2 Hospitals: South America Biosimilars Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.2 Speciality Clinics

10.2.1 Overview
10.2.2 Speciality Clinics: South America Biosimilars Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.3 Homecare

10.3.1 Overview
10.3.2 Homecare: South America Biosimilars Market – Revenue and Forecast, 2020-2028 (US$ Million)

11. South America Biosimilars Market – South and Central America Analysis

11.1 Overview

11.2 South and Central America

11.2.1 South America Biosimilars Market Breakdown, by Key Country, 2023 and 2028 (%)
11.2.1.1 South America Biosimilars Market – Revenue and Forecast Analysis – by Country
11.2.1.1 Brazil: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 Brazil: South America Biosimilars Market Breakdown, by Disease Indication
11.2.1.1.2 Brazil: South America Biosimilars Market Breakdown, by Drug Class
11.2.1.1.3 Brazil: South America Biosimilars Market Breakdown, by Route of Administration
11.2.1.1.4 Brazil: South America Biosimilars Market Breakdown, by End User

11.2.1.2 Argentina: South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Argentina: South America Biosimilars Market Breakdown, by Disease Indication
11.2.1.2.2 Argentina: South America Biosimilars Market Breakdown, by Drug Class
11.2.1.2.3 Argentina: South America Biosimilars Market Breakdown, by Route of Administration
11.2.1.2.4 Argentina: South America Biosimilars Market Breakdown, by End User

11.2.1.3 Rest of South and Central America : South America Biosimilars Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 Rest of South and Central America : South America Biosimilars Market Breakdown, by Disease Indication
11.2.1.3.2 Rest of South and Central America : South America Biosimilars Market Breakdown, by Drug Class
11.2.1.3.3 Rest of South and Central America : South America Biosimilars Market Breakdown, by Route of Administration
11.2.1.3.4 Rest of South and Central America : South America Biosimilars Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Amgen Inc

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Sanofi SA

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Biocon Ltd

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Eli Lilly and Co

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Sandoz AG

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Teva Pharmaceutical Industries Ltd

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Pfizer Inc

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Dr. Reddy's Laboratories Ltd

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

South America Biosimilars Market